Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome — Stella

Recruiting

Back to Neuroblastoma trials

Trial locations(1 site)

United States

Memorial Sloan Kettering Cancer Center, New York, New York

Key details

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Southern Illinois University, Spanish National Cancer Center

Enrollment target

~2,070 participants

Started

September 2000

Primary completion

September 2026

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov